Literature DB >> 20051424

Right ventricular hypertrophy and scarring in mutation positive hypertrophic cardiomyopathy.

Aoife N Keeling1, James C Carr, Lubna Choudhury.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20051424     DOI: 10.1093/eurheartj/ehp528

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

Review 1.  Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.

Authors:  Waseem Hindieh; Raymond Chan; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 2.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

Review 3.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 4.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

Review 5.  Hypertrophic cardiomyopathy. Proposal for a new classification.

Authors:  Guillermo A Llamas-Esperón; Guillermo Llamas-Delgado
Journal:  Arch Cardiol Mex       Date:  2022

Review 6.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

7.  CMR-derived TAPSE measurement: a semi-quantitative method of right ventricular function assessment in patients with hypertrophic cardiomyopathy.

Authors:  C Doesch; C Zompolou; F Streitner; D Haghi; R Schimpf; B Rudic; J Kuschyk; S O Schoenberg; M Borggrefe; T Papavassiliu
Journal:  Neth Heart J       Date:  2014-12       Impact factor: 2.380

8.  The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.

Authors:  Xiying Guo; Chaomei Fan; Lei Tian; Yanling Liu; Hongyue Wang; Shihua Zhao; Fujian Duan; Xiuling Zhang; Xing Zhao; Fengqi Wang; Hongguang Zhu; Aiqing Lin; Xia Wu; Yishi Li
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

Review 9.  Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy.

Authors:  Juan Carlos Brenes; Adelina Doltra; Susanna Prat
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

10.  Impaired Right Ventricular Mechanics at Rest and During Exercise Are Associated With Exercise Capacity in Patients With Hypertrophic Cardiomyopathy.

Authors:  Xiao-Peng Wu; Yi-Dan Li; Yi-Dan Wang; Miao Zhang; Wei-Wei Zhu; Qi-Zhe Cai; Wei Jiang; Lan-Lan Sun; Xue-Yan Ding; Xiao-Guang Ye; Yun-Yun Qin; Xiu-Zhang Lu
Journal:  J Am Heart Assoc       Date:  2019-03-05       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.